Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$781M |
| 2 |
Amazon
AMZN
|
+$728M |
| 3 |
AABA
Altaba Inc
AABA
|
+$535M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$296M |
| 5 |
Booking.com
BKNG
|
+$274M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$353M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$261M |
| 3 |
Alibaba
BABA
|
+$228M |
| 4 |
Citigroup
C
|
+$170M |
| 5 |
DuPont de Nemours
DD
|
+$165M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.47% |
| 2 | Technology | 2.03% |
| 3 | Consumer Discretionary | 1.46% |
| 4 | Financials | 1.01% |
| 5 | Healthcare | 0.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
PUT
Maximus
MMS
$3.14B
| $3.62M | ﹤0.01% |
57,800
+35,700
| +162% | +$2.22M |
|
2827
PUT
Lands' End
LE
$365M
| $3.62M | ﹤0.01% |
242,800
+34,400
| +17% | +$655K |
|
2828
Amplify Cybersecurity ETF
HACK
$2.96B
| $3.62M | ﹤0.01% |
+120,465
| New | +$3.59M |
|
|
EV
2829
DELISTED
Eaton Vance Corp.
EV
| $3.62M | ﹤0.01% |
+76,400
| New | +$3.48M |
|
2830
CALL
Direxion Daily MSCI India Bull 2X ETF
INDL
$56M
| $3.61M | ﹤0.01% |
48,400
+5,700
| +13% | +$431K |
|
2831
Enovis
ENOV
$1.44B
| $3.61M | ﹤0.01% |
53,279
+29,919
| +128% | +$2.04M |
|
|
2832
PUT
Enovis
ENOV
$1.44B
| $3.61M | ﹤0.01% |
53,278
+19,231
| +56% | +$1.31M |
|
2833
RLJ Lodging Trust
RLJ
$1.74B
| $3.61M | ﹤0.01% |
181,707
+56,558
| +45% | +$1.21M |
|
2834
Korn Ferry
KFY
$4.47B
| $3.61M | ﹤0.01% |
+104,532
| New | +$3.4M |
|
2835
Ormat Technologies
ORA
$6.31B
| $3.61M | ﹤0.01% |
61,503
+31,133
| +103% | +$1.83M |
|
2836
Robert Half
RHI
$4.64B
| $3.61M | ﹤0.01% |
75,300
-3,200
| -4% | -$150K |
|
2837
Carlyle Group
CG
$17.6B
| $3.6M | ﹤0.01% |
182,456
-70,504
| -28% | -$1.24M |
|
2838
iShares Biotechnology ETF
IBB
$10.5B
| $3.6M | ﹤0.01% |
34,869
-62,142
| -64% | -$6.12M |
|
|
BHI
2839
DELISTED
Baker Hughes
BHI
| $3.6M | ﹤0.01% |
+66,012
| New | +$3.79M |
|
2840
CALL
B2Gold
BTG
$7.41B
| $3.6M | ﹤0.01% |
1,279,900
+996,800
| +352% | +$2.63M |
|
|
CBPO
2841
CALL
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $3.6M | ﹤0.01% |
31,800
-39,800
| -56% | -$4.45M |
|
|
CHS
2842
CALL
DELISTED
Chicos FAS, Inc.
CHS
| $3.59M | ﹤0.01% |
381,400
-800
| -0.2% | -$9.24K |
|
2843
Cheniere Energy
CQP
$32.9B
| $3.59M | ﹤0.01% |
+110,869
| New | +$3.54M |
|
|
OTIC
2844
DELISTED
Otonomy, Inc.
OTIC
| $3.59M | ﹤0.01% |
+190,488
| New | +$2.66M |
|
|
EGN
2845
DELISTED
Energen
EGN
| $3.59M | ﹤0.01% |
+72,713
| New | +$3.88M |
|
2846
PUT
IMAX
IMAX
$2.76B
| $3.59M | ﹤0.01% |
163,100
+70,000
| +75% | +$1.96M |
|
2847
CALL
Ollie's Bargain Outlet
OLLI
$4.32B
| $3.59M | ﹤0.01% |
84,200
-27,100
| -24% | -$1.06M |
|
|
PACW
2848
CALL
DELISTED
PacWest Bancorp
PACW
| $3.59M | ﹤0.01% |
76,800
+36,200
| +89% | +$1.77M |
|
2849
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.4B
| $3.59M | ﹤0.01% |
192,196
+72,502
| +61% | +$1.32M |
|
|
SAGE
2850
DELISTED
Sage Therapeutics
SAGE
| $3.59M | ﹤0.01% |
+45,032
| New | +$3.26M |
|
Similar funds
Jeff Yass's Q2 2017 Portfolio in Review
As of Q2 2017, Jeff Yass held 10,525 positions worth $228B, up 15% from $198B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Jeff Yass's Q2 2017 filing shows 1,702 new, 3,804 increased, 3,457 reduced and 1,419 closed positions. Its largest new stake was Altaba Inc: 9,835,232 shares worth $536M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $353M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 92% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q2 2017 buy was Altaba Inc: 9,835,232 shares worth $536M.
- Jeff Yass added most to Apple in Q2 2017, an estimated $781M increase.
- Jeff Yass's biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $353M.
- Jeff Yass fully exited Alphabet (Google) Class C in Q2 2017, selling an estimated $261M.
- Jeff Yass's ten largest holdings make up 22% of its $228B portfolio in Q2 2017.
- Jeff Yass opened 1,702 new positions and closed 1,419 in Q2 2017.
- Jeff Yass's portfolio value rose 15% quarter-over-quarter to $228B.
Based on Susquehanna International Group's 13F filing for Q2 2017, filed 15 Aug 2017.